title: Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei.
abstract: Because of Burkholderia pseudomallei's classification as a select agent in the United States, genetic manipulation of this bacterium is strictly regulated. Only a few antibiotic selection markers, including gentamicin, kanamycin, and zeocin, are currently approved for use with this bacterium, but wild-type strains are highly resistant to these antibiotics. To facilitate routine genetic manipulations of wild-type strains, several new tools were developed. A temperature-sensitive pRO1600 broad-host-range replicon was isolated and used to construct curable plasmids where the Flp and Cre recombinase genes are expressed from the rhamnose-regulated Escherichia coli P(BAD) promoter and kanamycin (nptI) and zeocin (ble) selection markers from the constitutive Burkholderia thailandensis ribosomal P(S12) or synthetic bacterial P(EM7) promoter. Flp and Cre site-specific recombination systems allow in vivo excision and recycling of nptII and ble selection markers contained on FRT or loxP cassettes. Finally, expression of Tn7 site-specific transposase from the constitutive P1 integron promoter allowed development of an efficient site-specific chromosomal integration system for B. pseudomallei. In conjunction with a natural transformation method, the utility of these new tools was demonstrated by isolating an unmarked delta(amrRAB-oprA) efflux pump mutant. Exploiting natural transformation, chromosomal DNA fragments carrying this mutation marked with zeocin resistance were transferred between the genomes of two different B. pseudomallei strains. Lastly, the deletion mutation was complemented by a chromosomally integrated mini-Tn7 element carrying the amrAB-oprA operon. The new tools allow routine select-agent-compliant genetic manipulations of B. pseudomallei and other Burkholderia species.
authors.affiliation: Department of Microbiology, Immunology and Pathology, Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, Colorado State University, Fort Collins, CO 80523-1682, USA.
authors.forename: Kyoung-Hee
authors.initials: KH
authors.lastname: Choi
authors.forename: Takehiko
authors.initials: T
authors.lastname: Mima
authors.forename: Yveth
authors.initials: Y
authors.lastname: Casart
authors.forename: Drew
authors.initials: D
authors.lastname: Rholl
authors.forename: Ayush
authors.initials: A
authors.lastname: Kumar
authors.forename: Ifor R
authors.initials: IR
authors.lastname: Beacham
authors.forename: Herbert P
authors.initials: HP
authors.lastname: Schweizer
mesh_terms: D001483:Base Sequence; D001761:Bleomycin; D016957:Burkholderia pseudomallei / Q000235:genetics*; D003001:Cloning, Molecular; D017931:DNA Primers / Q000235:genetics; D024881:Drug Resistance, Bacterial / Q000235:genetics; D005821:Genetic Techniques; D008969:Molecular Sequence Data; D010957:Plasmids / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics; D012093:Replicon / Q000235:genetics; D014169:Transformation, Bacterial / Q000235:genetics*; D019895:Transposases / Q000235:genetics
chemical_list: D017931:DNA Primers; D001761:Bleomycin; C105427:Zeocin; D019895:Transposases